Manufacturers may need to reformulate or re-label more than 2,000 OTC antibacterial soaps unless they can prove by December 2014 that the products are safe for long-term, frequent use and that they more effectively prevent illness than plain soap and water, FDA says.
The agency hopes to finalize a proposed rule by September 2016 to amend the tentative final monograph for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?